Submit your email to push it up the queue
Liberty Medical Supply, Inc., headquartered in the United States, is a leading provider in the medical supply industry, specialising in diabetes management and durable medical equipment. Founded in 2001, the company has established a strong presence across various operational regions, focusing on delivering high-quality products and exceptional customer service. Liberty Medical Supply offers a comprehensive range of core products, including insulin pumps, glucose monitors, and diabetic supplies, all designed to enhance patient care and improve health outcomes. What sets them apart is their commitment to personalised service and innovative solutions tailored to individual needs. With a reputation for reliability and excellence, Liberty Medical Supply has achieved significant milestones, positioning itself as a trusted partner for healthcare providers and patients alike. Their dedication to quality and customer satisfaction continues to drive their success in the competitive medical supply market.
How does Liberty Medical Supply, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Liberty Medical Supply, Inc.'s score of 65 is higher than 81% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Liberty Medical Supply, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. The company is a current subsidiary of Cardinal Health, Inc., and therefore, any climate commitments or emissions data may be inherited from its parent organisation. As of now, there are no documented reduction targets or climate pledges specific to Liberty Medical Supply, Inc. However, it is important to note that the climate initiatives and performance metrics may be influenced by Cardinal Health, Inc., which operates under various sustainability frameworks, including the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). Given the absence of direct emissions data and reduction targets for Liberty Medical Supply, Inc., stakeholders may need to refer to Cardinal Health, Inc. for comprehensive insights into their climate commitments and performance.
Access structured emissions data, company-specific emission factors, and source documents
2009 | 2010 | 2016 | 2017 | 2018 | 2019 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|---|---|
Scope 1 | 148,856,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | 212,644,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | - | - | - | - | 00,000,000 | - | - | - | 00,000,000,000 | 00,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Liberty Medical Supply, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.